These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 20686144)

  • 1. Successful treatment with amisulpride for poststroke psychosis.
    Chen JH; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2010; 22(3):352.e1. PubMed ID: 20686144
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of amisulpride and olanzapine in treatment-resistant schizophrenic psychoses.
    Zink M; Henn FA; Thome J
    Eur Psychiatry; 2004 Feb; 19(1):56-8. PubMed ID: 14969782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amisulpride: a treatment option for psychotic disorders soon to be available in the Netherlands].
    Vinkers CH; Sommer IE
    Tijdschr Psychiatr; 2015; 57(11):830-4. PubMed ID: 26552930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amisulpride-induced mania with interictal psychosis.
    Bakhla AK; Goyal N; Nizamie SH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1572-3. PubMed ID: 19766159
    [No Abstract]   [Full Text] [Related]  

  • 5. Improvement of amisulpride-induced extrapyramidal symptoms with quetiapine.
    Jagadheesan K; Muirhead D
    Aust N Z J Psychiatry; 2004 Jul; 38(7):560. PubMed ID: 15255830
    [No Abstract]   [Full Text] [Related]  

  • 6. Amisulpride treatment of somatoform disorders: not just chronic fatigue.
    Goswami K; Saddichha S; Chaturvedi SK
    Am J Ther; 2014; 21(2):e48-9. PubMed ID: 23011165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of bromocriptine in the treatment of amisulpride-induced hyperprolactinemia: a case report.
    Bliesener N; Yokusoglu H; Quednow BB; Klingmüller D; Kühn KU
    Pharmacopsychiatry; 2004 Jul; 37(4):189-91. PubMed ID: 15467977
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode].
    Barrimi M; El Ghazouani F; Zaimi O; Oneib B
    Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amisulpride in Huntington's disease].
    Saft C; Andrich J; Kraus PH; Przuntek H
    Psychiatr Prax; 2005 Oct; 32(7):363-6. PubMed ID: 16220421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotic disorder as a manifestation of Graves' disease.
    Katsigiannopoulos K; Georgiadou E; Pazarlis P; Karastergiou A; Papazisis G; Bozikas V; Garyfallos G
    Psychosomatics; 2010; 51(5):449-50. PubMed ID: 20833948
    [No Abstract]   [Full Text] [Related]  

  • 11. A successful antipsychotic combination trial. Quo Vadis?
    Stahl S; Freudenreich O; Goff D
    Acta Psychiatr Scand; 2004 Oct; 110(4):241-2. PubMed ID: 15352924
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression.
    Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amisulpride treatment of adolescent patients with schizophrenia or schizo-affective disorders.
    Varol Tas F; Guvenir T
    Eur Child Adolesc Psychiatry; 2009 Aug; 18(8):511-3. PubMed ID: 19267176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperprolactinaemia and acute psychosis: prolactinoma or medication-induced phenomenon?
    Höfer P; Friedrich F; Vyssoki B; Spindelegger C; Schmook M; Barnas C; Lesch OM; Walter H
    World J Biol Psychiatry; 2010 Aug; 11(5):759-61. PubMed ID: 20446883
    [No Abstract]   [Full Text] [Related]  

  • 15. [Solian: evaluation of 10 years' experimentation and clinical practice].
    Baldauf A; Metzger JY; Sichel JP
    Ann Med Psychol (Paris); 1988; 146(1-2):63-6. PubMed ID: 2901244
    [No Abstract]   [Full Text] [Related]  

  • 16. Temporal lobe epilepsy masquerading as psychosis--a case report and literature review.
    Needham E; Hamelijnck J
    Neurocase; 2012; 18(5):400-4. PubMed ID: 22124330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of amisulpride in treating primary negative symptoms in first-episode psychosis: a pilot study.
    Murphy BP; Stuart AH; Wade D; Cotton S; McGorry PD
    Hum Psychopharmacol; 2006 Dec; 21(8):511-7. PubMed ID: 17066489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T; Liappas J; Tzavellas E; Mourikis I; Soldatos C
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):92-6. PubMed ID: 16938372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation.
    Kreinin A; Miodownik C; Sokolik S; Shestakova D; Libov I; Bergman J; Lerner V
    World J Biol Psychiatry; 2011 Dec; 12(8):620-6. PubMed ID: 20964499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amisulpride versus risperidone treatment for behavioral and psychological symptoms in patients with dementia of the Alzheimer type: a randomized, open, prospective study.
    Lim HK; Pae CU; Lee C; Lee CU
    Neuropsychobiology; 2006; 54(4):247-51. PubMed ID: 17356308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.